2020 CLIC Virtual Un-Meeting Clinical Research in the COVID-era and Beyond
Register to attend HERE
This NCATS “rapid-response” Un-Meeting will encourage discussions around the changes encountered in the area of clinical and translational research resulting from the COVID pandemic. Other potential topics include Identifying clinical research trial design opportunities as a unified network in the post-COVID clinical era? What does training look like? What do remote trials look like? What is the impact on recruitment? Furthermore, what is the role of CTSA Program in clinical research post-COVID.
Questions Contact Us
Confirmed Speakers to date;
Jonathan Sexton, Ph.D - University of Michigan - Drug repurposing for COVID-19
Chris Lindsell, Ph.D - Vanderbilt University - Sharing information between DSMBs to learn quickly during a public health emergency
Roger J. Lewis, M.D., Ph.D - UCLA - Replacing the One-dimensional Trial (One question, one population, one treatment, one start, one end, and one waste of resources)
Earl Ray Dorsey, M.D., MBA - University of Rochester - The future of clinical trials
Daniel E. Ford, MD, MPH - Johns Hopkins University / Trial Innovation Network - TBA
Karen A. Monsen, PhD, RN, FAMIA, FAAN / Robin R. Austin, PhD, DNP, DC, RN-BC - University of Minnesota - Engaging communities in COVID-19 research: Social determinants, resilience, and whole-person health.
Rochester, NY 14642